Status:

COMPLETED

Qsymia as an Adjunct to Surgical Therapy in the Superobese

Lead Sponsor:

Wake Forest University Health Sciences

Collaborating Sponsors:

VIVUS LLC

Conditions:

Obesity

Metabolic Surgery

Eligibility:

All Genders

18-70 years

Phase:

PHASE2

Brief Summary

This study tests the efficacy of the medication, Qsymia, as an adjunct therapy in superobese individuals planning to undergo weight loss surgery. Individuals taking the medication before and after sur...

Detailed Description

While there is obvious focus on the obesity epidemic that affects approximately one-third of the U.S. population, one subgroup within the epidemic remains on the fringe of scientific study and effecti...

Eligibility Criteria

Inclusion

  • BMI ≥ 50 kg/m2
  • Determined to be a good candidate for surgery based on medical and psychological exam.
  • Willing to participate in a 3-6 month medically supervised weight loss plan prior to surgery.
  • Planning to remain in the reasonable vicinity of the Wake Forest Baptist Health - Weight Management Center for the duration of the study.

Exclusion

  • History of prior weight loss surgery (removal/conversion from band to sleeve will not be excluded)
  • Pregnant (women of childbearing potential will complete a pregnancy test (blood draw) to make sure they are not pregnant at the time that they initiate the medication). Ongoing monitoring of pregnancy status is the responsibility of the patient and they are instructed as such in the consent form.
  • Ongoing use of weight loss medication
  • Contraindications to use of Qsymia, including pregnancy, history of glaucoma, unstable cardiac disease (unstable angina, recent heart attack or stroke (in the past 6 months), uncontrolled arrhythmia), hyperthyroidism, taking monoamine oxidase inhibitors (MAOIs) or allergy to either topiramate or sympathomimetic amines like phentermine.

Key Trial Info

Start Date :

December 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 27 2018

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT02301416

Start Date

December 1 2014

End Date

June 27 2018

Last Update

September 4 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Wake Forest Baptist Health

Winston-Salem, North Carolina, United States, 27157

Qsymia as an Adjunct to Surgical Therapy in the Superobese | DecenTrialz